<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikianesthesia.org/w/index.php?action=history&amp;feed=atom&amp;title=Fat_embolism</id>
	<title>Fat embolism - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikianesthesia.org/w/index.php?action=history&amp;feed=atom&amp;title=Fat_embolism"/>
	<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Fat_embolism&amp;action=history"/>
	<updated>2026-05-05T10:10:06Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.37.1</generator>
	<entry>
		<id>https://wikianesthesia.org/w/index.php?title=Fat_embolism&amp;diff=16368&amp;oldid=prev</id>
		<title>JVD: Created this, text from OpenAnesthesia</title>
		<link rel="alternate" type="text/html" href="https://wikianesthesia.org/w/index.php?title=Fat_embolism&amp;diff=16368&amp;oldid=prev"/>
		<updated>2024-04-08T15:34:12Z</updated>

		<summary type="html">&lt;p&gt;Created this, text from OpenAnesthesia&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Infobox comorbidity&lt;br /&gt;
| other_names = &lt;br /&gt;
| anesthetic_relevance = &lt;br /&gt;
| specialty = &lt;br /&gt;
| signs_symptoms = &lt;br /&gt;
| diagnosis = &lt;br /&gt;
| treatment = &lt;br /&gt;
| image = &lt;br /&gt;
| caption = &lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
Provide a brief summary of this comorbidity here.&lt;br /&gt;
&lt;br /&gt;
== Anesthetic implications&amp;lt;!-- Briefly summarize the anesthetic implications of this comorbidity. --&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
=== Preoperative optimization&amp;lt;!-- Describe how this comorbidity may influence preoperative evaluation and optimization of patients. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Intraoperative management&amp;lt;!-- Describe how this comorbidity may influence intraoperative management. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Postoperative management&amp;lt;!-- Describe how this comorbidity may influence postoperative management. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
== Related surgical procedures&amp;lt;!-- List and briefly describe any procedures which may be performed specifically to treat this comorbidity or its sequelae. If none, this section may be removed. --&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
== Pathophysiology&amp;lt;!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --&amp;gt; ==&lt;br /&gt;
Fat embolism syndrome (FES) is a physiologic response to fat embolism. While fat embolization is quite common, likely occurring in nearly all patients with a femoral or pelvic fracture, fat embolization syndrome occurs in less than 1% of these patients. FES may develop over 12-72 hours or may present as fulminant disease with respiratory failure and cardiac arrest. A diagnosis based on the Gurd diagnostic criteria requires the presence of fat microemboli in the blood along with 1 major (respiratory insufficiency, cerebral involvement, or petechial rash) plus 4 minor criteria (pyrexia, tachycardia, retinal changes, jaundice, or renal changes). &lt;br /&gt;
&lt;br /&gt;
== Signs and symptoms&amp;lt;!-- Describe the signs and symptoms of this comorbidity. --&amp;gt; ==&lt;br /&gt;
A petechial rash is considered pathognomonic for the syndrome and can be seen on conjunctiva, oral mucosa, and skin folds. Although mild hypoxia is common, less than 10% of patients with FES develop acute respiratory distress syndrome (ARDS). The pathophysiology of FES likely involves both the obstruction of end-organ capillaries by microemboli along with a systemic inflammatory response. Large emboli may cause segmental wall motion abnormalities, elevated pulmonary artery pressures, right ventricular dysfunction, and cardiac arrest.&lt;br /&gt;
&lt;br /&gt;
== Diagnosis&amp;lt;!-- Describe how this comorbidity is diagnosed. --&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
== Treatment&amp;lt;!-- Summarize the treatment of this comorbidity. Add subsections as needed. --&amp;gt; ==&lt;br /&gt;
Treatment of fat embolism syndrome consists of supportive care and early resuscitation with prompt supplemental oxygen and intubation if necessary. &lt;br /&gt;
&lt;br /&gt;
=== Medication&amp;lt;!-- Describe medications used to manage this comorbidity. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Surgery&amp;lt;!-- Describe surgical procedures used to treat this comorbidity. --&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
=== Prognosis&amp;lt;!-- Describe the prognosis of this comorbidity --&amp;gt; ===&lt;br /&gt;
Most symptoms resolve within 3-7 days. &lt;br /&gt;
&lt;br /&gt;
== Epidemiology&amp;lt;!-- Describe the epidemiology of this comorbidity --&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
Schonfeld SA, Ploysongsang Y, DiLisio R, et al. Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med. 1983;99(4):438-443. doi:10.7326/0003-4819-99-4-438                                                                                                        &lt;br /&gt;
&lt;br /&gt;
Gurd AR, Wilson RI. The fat embolism syndrome. J Bone Joint Surg Br. 1974;56B(3):408-416.                                                                                                    &lt;br /&gt;
[[Category:Comorbidities]]&lt;/div&gt;</summary>
		<author><name>JVD</name></author>
	</entry>
</feed>